| Literature DB >> 34009648 |
Diana Stan1,2, Cristiana Tanase2,3, Marioara Avram1, Roxana Apetrei1, Nicolae-Bogdan Mincu1, Andreea Lorena Mateescu1, Dana Stan1.
Abstract
Although superficial wounds are often easy to treat for healthy individuals, there are some more severe types of wounds (burns, ulcers, diabetic wounds, etc.) that are a challenge for clinicians. A good therapeutic result is based on the delivery of a treatment at the right time, for the right patient. Our goal was to sum up useful knowledge regarding wound healing and wound treatments, based on creams and hydrogels with various active ingredients. We concluded that both preparations have application in preventing infections and promoting healing, but their efficacy is clearly conditioned by the type, depth, severity of the wound and patient profile. However, due to their superior versatility and capability of maintaining the integrity and functionality of the active ingredient, as well as it is controlled release at site, hydrogels are more suited for incorporating different active ingredients. New wound healing devices can combine smart hydrogel dressings with physical therapies to deliver a more efficient treatment to patients if the indications are appropriate.Entities:
Keywords: creams; smart hydrogels; wound classification; wound dressing; wound healing
Mesh:
Substances:
Year: 2021 PMID: 34009648 PMCID: PMC8453519 DOI: 10.1111/exd.14396
Source DB: PubMed Journal: Exp Dermatol ISSN: 0906-6705 Impact factor: 3.960
FIGURE 1Basic anatomy of skin
FIGURE 2Skin functions. The barrier function is one of the most important functions of the skin, because it maintains the body's homeostasis and protects against pathogens, chemicals, radiation and mechanical damage
FIGURE 3Indicators used for wound assessment during clinical evaluation
Characteristics, effects and applications of hydrogels
| Types of hydrogels/applications | Basic material | Hydrogel fabrication pathways | Hydrogel effect/property | References |
|---|---|---|---|---|
| Hydrogels containing antibiotics | Polyethylene glycol (PEG) | Conjugated DNA oligonucleotides to polyethylene glycol using free radical polymerization and tetracycline | Tetracycline could inhibit bacterial growth within 48 h and induce the formation of zones of inhibition on the agar plate |
|
| Keratin hydrogels | Lyophilized oxidized keratin was weighed and hydrated with ciprofloxacin | Burns treated with ciprofloxacin‐ keratin hydrogels contained significantly less |
| |
| Polyvinyl alcohol‐gelatin (PVA) | Gentamicin and serratiopeptidase were incorporated into PVA‐gelatin hydrogel | Natural debridement by hydrating necrotic tissue with loosening and absorbing slough and exudate in wounds. It also encourages autolytic debridement |
| |
| Hydrogels used for the delivery of stem cells |
Adipose Extracellular Matrix (ECM), Methylcellulose (MC) | ECM solution prepared by the dilution of lyophilized ECM in phosphate‐buffered saline solution (PBS), while MC was prepared by dispersion technique |
Accelerated wound closure, re‐epithelialization, neovascularization |
|
| Collagen‐ Polyethylene glycol, fibrin | Debrided skin adipose stem cells mixed with collagen and then PEG was added to the collagen, followed by the addition of fibrin |
Less wound contraction Dermal matrix deposition |
| |
| Pullulan–collagen | Pullulan‐collagen were added to Adipose‐derived mesenchymal stem cells suspended in growth media using a capillary force method | Accelerated wound closure, improve cell recruitment and functionality, neovascularization |
| |
| Pluronic F127 | Pluronic F127 powder was dissolved in PBS before encapsulation of allogeneic non‐diabetic adipose‐derived stem cells | Angiogenesis resulted from the cells in the hydrogel cell proliferation, accelerated wound closure, regeneration of granulation tissue |
| |
| Chitosan and gelatin | 8 ml of 2% chitosan mixed with 2 ml of 2%/4% gelatin solution. Adipose‐derived stem cells were encapsulated in the chitosan‐gelatin hydrogel | Faster cell migration at the wound site, angiogenesis, higher capillary density |
| |
| Hydrogels used for the delivery of bioactive agents | Mixture of polyvinyl acetate (PVA), gelatin and chitosan | 3% chitosan solution prepared in a 3% acetic acid solution; PVA was dissolved in distilled water; 5% gelatin solution dissolved in distilled water. Gel mixture was prepared in a ratio of 2:1:1 of chitosan/PVA/gelatin | Accelerated wound closure, re‐epithelization; faster transition from the inflammatory to the maturation phase, enhanced collagen deposition, myofibroblasts and vessel formation |
|
| Polyvinylpyrrolidone/polyethylene glycol‐dimethacrylate (PVP/PEG‐DMA) | Cyclodextrins (CD) attached to the PVP/PEG‐DMA | β‐CDs immobilized in the PVP/PEG‐DMA matrix stimulated a prolonged release of ibuprofen |
| |
|
Heparin Poloxamer | Heparin–poloxamer (HP) conjugate was prepared with Ethylene dichloride/N‐hydroxysuccinimide (EDC/NHS) as coupling agents and then HP with growth factor Acid fibroblast growth factor (aFGF) hydrogels and HP‐ with growth factor Basic fibroblast growth factor (bFGF) hydrogels were prepared by lyophilizing HP powder and mixing it with aFGF / bFGF | Improved wound closure, re‐epithelialization |
| |
| PEG and heparin | 40% thiolated heparin and 6 kilodalton (kDa) PEG in a 1:1 ratio was dissolved in PBS | Advanced granulation tissue formation, capillary formation, and re‐epithelialization |
| |
| Alginate sulphate | Alginate sulphate hydrogel was made by photo‐crosslinking method and methacrylate. Then a human growth factor was added | Higher presence of collagen and of hair follicles, improved vascularization, reduced inflammation |
| |
| Hyaluronic Acid(HA)–MMP | Hydrogels were formed by the addition of acrylate‐ functionalized HA with bis‐cysteine containing MMP at pH 8.0–8.2 | Enhanced granulation tissue formation, angiogenesis |
| |
| Gelatin | Gelatin hydrogel was prepared by crosslinking of phenol with horseradish peroxidase and hydrogen peroxide | Facilitated cell infiltration into the wound area, accelerated wound healing, enhanced re‐epithelialization/neovascularization, increased collagen deposition |
| |
| Sodium alginate/bioglass hydrogel | 1 ml of 2% (w/v) sodium alginate solution mixed with 20 mg bioglass powders and 20 mg gluconic acid δlactone | Polarization of macrophages, upregulation of anti‐inflammatory genes, recruitment of fibroblasts and endothelial cells, improvement of the extracellular matrix |
| |
| Hydrogels used for skin substitution | Collagen | Collagen hydrogel was created through combination of type I collagen along with fractionated platelet‐rich plasma | Accelerated wound healing, angiogenesis, hair and sweat gland formation, regenerating a dermis‐like tissue |
|
| Photocrosslinkable gelatin acrylamide (GelMA) | The gelatin was modified by hydroxyphenyl propionic acid | Excellent cell viability (>90%) with increasing cell adhesion and proliferation corresponding to increases in hydrogel concentrations. Support keratinocyte growth, differentiation, and stratification into a reconstructed multilayered epidermis |
| |
| Pullulan‐Gelatin hydrogel | Modification of gelatin with photocrosslinkable methacrylamide groups | Promotes skin regeneration, less macrophage infiltration and increased angiogenesis; decreased inflammation |
| |
| Smart hydrogels stimuli‐responsive hydrogels | Aldehyde hyaluronic acid (A‐HA) / adipic acid dihydrazide graft hyaluronic acid (HA‐ADH) / sisomicin sulphate (SS) hydrogel | Evenly mixing A‐HA, HA‐ADH and SS | pH‐ and HAase‐dependent degradability that enables the release of more aminoglycosides‐SS for on‐demand and sustained anti‐infection and antioxidant activity |
|
| Sodium alginate/poly (N‐vinyl caprolactam) | N‐vinyl caprolactam polymerized in an aqueous sodium alginate followed by chemical and ionic crosslinking. Tannic acid incorporated hydrogels were also fabricated | Temperature‐pH dual responsive hydrogel with excellent free radical scavenging, anti‐inflammatory, antibacterial effect |
| |
| Alginate/polyacrylamide hydrogel matrix | Phenol red was modified with methacrylate to allow copolymerization with the hydrogel matrix | The colour of the hydrogel changes from yellow (pH 5,6 and 7) to orange (7.4 and 8), and finally to red (pH 9). This range of colour change matches the clinically meaningful pH range of chronic or infected wounds |
| |
| Sodium alginate/bioglass composite hydrogel | Sodium alginate (SA) microparticles containing conditioned medium (CM) of cells (SACM). Inside the SACM microparticles, poly(lactic‐co‐glycolic acid) microspheres containing pirfenidone were encapsulated | The hydrogel system sequentially delivers bioactive molecules for meeting the biologic requirements and timeline of each wound healing stage |
|
Abbreviations: aFGF, Acid fibroblast growth factor; A‐HA, Aldehyde hyaluronic acid; CD, Cyclodextrins; CM, Conditioned medium; ECM, Adipose Extracellular Matrix; EDC/NHS, Ethylene dichloride/N‐hydroxysuccinimide; GelMA, Photocrosslinkable gelatin acrylamide; HA, Hyaluronic Acid; HA‐ADH, Adipic acid dihydrazide graft hyaluronic acid; HP, Heparin–poloxamer; kDa, Basic fibroblast growth factor (bFGF); Kilodalton; MC, Methylcellulose; N‐vinyl caprolactam, Sodium alginate/poly; PBS, Phosphate‐buffered saline solution; PEG, Polyethylene glycol; PVA, Polyvinyl acetate; PVA, Polyvinyl alcohol‐gelatin; PVP/PEG‐DMA, Polyvinylpyrrolidone/polyethylene glycol‐dimethacrylate; SA, Sodium alginate; SS, Sisomicin sulphate.
Summary of cream types and their applications
| Type of cream | Pathology | Active substances | Activity domain | References |
|---|---|---|---|---|
| Aloe vera | Topical injuries, pathologically induced wounds, cancer treatment‐related injuries, different degree burns, skin transplant. | Flavonoid terpenoid, lectin, anthraquinone, tannin and saponin |
Antifungal, antiseptic, antiviral, antibacterial, anti‐inflammatory, antioxidant, and wound healing properties, stimulating fibroblast activity and collagen proliferation. Potential effect to increase the ratio of CD4+/CD8+ lymphocytes, CD4+ playing a crucial role as healing promotor to cellular immune response by decreasing percentage of the wound area, neutrophils infiltration, and angiogenesis | |
| 1% Silver Sulphadiazine Cream | Wound infections in patients with second‐ and third‐degree burns, severe burns or burns over a large area of the body | Silver nitrate, sulphonamide sodium sulphadiazine | Increase fibroblasts, macrophages and epidermal cells activities, subsequently, facilitate enzyme activity during collagen remodelling and even aids the formation of cross linkage improving in the tensile strength of the wound |
|
| 1% Phenytoin cream | Ulcers, epidermolysis bullosa and inflammatory conditions | 100mg Phenytoin sodium, lactose monohydrate, confectioner's sugar, talc, magnesium stearate |
Significantly increased fibroblasts generating an accelerated healing process, reducing the wound surface. Phenytoin treatment preferentially induces a Th2‐type response, depresses interferon augmentation of natural killer cell cytotoxicity in a dose‐dependent manner |
|
| Dexpanthenol | To treat or prevent dry, rough, scaly, |
20.0% Dexpanthenol, 20.0% Argania spinosa kernel oil, 20.0% Polyglyceryl−3‐ polyricinoleate,30.0% Emollient, 50.0% Emulsifier and surfactants, 5.0% Antioxidants, 5.0% preservatives by weight of total composition | Dexpanthenol is well absorbed when applied topically to the skin and rapidly converted to pantothenic acid enhancing epidermal differentiation and facilitates wound healing; it also showed activity in the prevention of biofilm formation and has anti‐inflammatory effects, moisturizer and skin barrier enhancer |
|
| Hirudoid, sulphonic acid mucopolysaccharide and dexamethasone | Phlebitis | Hirudoid, sulphonic acid mucopolysaccharide and dexamethasone | Improving phlebitis symptoms, shortening time of elimination of red swelling, time of pain relief at the location and time of resolution of phlebitis |
|
| Framycetin cream | Burns, irritation, itching and redness | Emulsifiers, waxy materials, co‐solvents, acids, preservatives, buffering agents, antioxidants, chelating agents, and humectants and water | Reduced recovery time, the absence of wound infection, the lack of redness and itching by decreasing histamine activity, up to 9 days by using it twice a day |
|
| Cetuximab |
Metastatic Colorectal Cancer (cancer spread beyond the colon or rectum) Squamous Cell Cancer of the Head and Neck Non‐small Cell Lung Cancer Squamous Cell Skin Cancer | Chimeric monoclonal IgG1 antibody produced in a mammalian cell line (Sp2/0) by recombinant DNA technology | Rash induced by cancer is significantly reduced to grade 1 |
|
FIGURE 4Specific properties of creams (right) and hydrogels (left) that can be both beneficial and detrimental, depending on the wound type